Thyrocare Technologies Q2 Results
- BSE: 539871
- NSE: THYROCARE
- ISIN: INE594H01019
- Sector: Healthcare Facilities
BSE
403.10
-3.20 (-0.79%)
-3.20 (-0.79%)Volume12.13 K
Updated: Wed 11 Feb, 2026 | 12:10:23
NSE
406-0.35 (-0.09%)
-0.35 (-0.09%)Volume3.26 L
Updated: Wed 11 Feb, 2026 | 12:02:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Thyrocare Technologies Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 156.69 | 146.67 | 6.83% | 142.14 | 10.24% |
| Depreciation/ Amortization | 11.51 | 11.41 | 0.88% | 13.07 | -11.94% |
| Operating Income | 59.84 | 46.36 | 29.08% | 35.22 | 69.90% |
| Net Income | 47.99 | 38.93 | 23.27% | 26.68 | 79.87% |
| Other Operating Expenses Total | 51.89 | 46.63 | 11.28% | 48.59 | 6.79% |
| Net Income Before Taxes | 62.58 | 50.48 | 23.97% | 36.78 | 70.15% |
| Total Revenue | 216.53 | 193.03 | 12.17% | 177.36 | 22.09% |
| Selling/ General/ Admin Expenses Total | 33.23 | 33.00 | 0.70% | 29.49 | 12.68% |
| Diluted Normalized EPS | 3.01 | 2.44 | 23.19% | 1.66 | 81.33% |